Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-4062.15	-147.58	-3.55
Graham Fair Price	-85.33	613.73	4183.96
PEG	12765.90	0.04	< 0.005
Price/Book	-41.91	-0.25	-0.17
Price/Cash Flow	-1316.52	-7.16	-0.51
Prices/Earnings	-6803.02	-3.52	-0.05
Price/Sales	2739.71	3.33	-0.12
Price/FCF	-1316.52	-7.16	-0.51
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	590.28	0.18	0.03
Operating Margin	50.56	-0.14	0.09
ROA	97.61	-0.04	-1.80
ROE	0.85	0.02	-97.94
ROIC	0.26	0.08	-67.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.78	-0.39	97.90
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.42	0.92	120.12
EPS QOQ	-1.82	0.98	-46.35
FCF QOQ	-1.01	0.90	-11.29
Revenue QOQ	-2.90	1.05	-63.68
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-2.37	60.76	2459.55
Days Sales Outstanding (DSO)	-8.06	165.78	1955.87
Inventory Turnover	-37.91	1.48	-96.09
Debt/Capitalization	-1.09	-7.14	-553.88
Quick Ratio	0.14	0.11	-22.99
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-955.34	-977.39	-2.31
Cash	81.06	23.08	-71.52
Capex	54.22	-4.18	-92.30
Free Cash Flow	-328.35	-33.65	89.75
Revenue	-1414.71	72.33	-94.89
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.17	0.15	-14.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.56	-115.45	-4416.91
Naive Interpretation	Member

06 - Financial Health · Bad

Rating